Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Medicine » Hematologic Disorders » Deep Vein Thrombosis: Symptoms, Diagnosis and Treatments Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Central Asia: Perspectives and Present Challenges
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Clinical approach in deep vein thrombosis (pp. 1-10)
Tell A Friend
Tell someone you know about this product.
Clinical approach in deep vein thrombosis (pp. 1-10) $100.00
Authors:  (C. Rinaldi A. Lesmana and Aru W. Sudoyo)
Deep venous thrombosis (DVT) is part of disease called venous thromboembolism (VTE) and is a life threatening condition that can lead to death. The annual incidence is 67 per 100,000 among general population. The primary mechanism is the Virchow triad, which are venous stasis, vessel wall injury, and hypercoagulable state. A balance between thrombogenesis and the body's protective mechanisms (inhibitors of coagulation and the fibrinolytic system) has the important role of venous thrombosis incidence. There are several factors that might contribute to this event, such as genetic factors, and acquired factors (long-haul air travel, cigarette smoking, pregnancy, obesity, oral contraceptive, post-menopausal hormone replacement, surgery, trauma, and others medical conditions like antiphospholipid antibody syndrome, cancer, hypertension, and chronic pulmonary obstructive disease). The
clinical evaluation is very challenging since the symptoms and signs are non-specific. Patients usually have a cramp in the lower calf that persists for several days. Physical findings can shows mild palpation discomfort in the lower calf. In massive DVT, patient presents severe thigh swelling and marked tenderness when palpating the inguinal area and common femoral vein. The diagnosis can be established via clinical prediction rules, D-dimer (a degradation product of a cross-linked fibrin blood clot) testing, and imaging examination like compression ultrasonography with Doppler. It has been well established that a clinical prediction rule that takes into account signs, symptoms and risk factors can be applied to categorize patients as having low, moderate or high probability of DVT. The differential diagnoses for DVT are ruptured Bakerís cyst, cellulitis, and post-phlebitic syndrome/venous insufficiency. The main goal of DVT management is to prevent the extension of thrombus and pulmonary embolism in the short-term and to prevent recurrent events in the long-term. The standard therapy for DVT is heparin (unfractionated heparin/UFH or low molecular weight heparin/LMWH). The advantage of UFH is that it has a short half-life. Its anticoagulant effect abates after several hours. The disadvantage of UFH is that achieving aPTT target can be difficult and may require repeated blodd sampling and heparin dose adjustment every 4-6 hours. The route of administration and efficacy of LMWH make this the preferred anticoagulant. Based on a meta-analysis comparing the effectiveness of LMWH at a fixed dose with UFH at an adjusted dose, significantly fewer deaths, major hemorrhages and recurrent venous thromboembolisms occurred with the LMWH. 

Available Options:
This Item Is Currently Unavailable.
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2021

Clinical approach in deep vein thrombosis (pp. 1-10)